Department of Cardiology, Central Hospital of Nanchong, The Second Clinical School of North Sichuan Medical College, Nanchong, China.
Department of Cardiology, The first affiliated hospital of chongqing medical university, Chongqing, China.
Sci Rep. 2017 Oct 16;7(1):13207. doi: 10.1038/s41598-017-13267-6.
Few studies has investigated the interrelationship between Atherogenic index of plasma (AIP) and coronary heart disease (CHD) especially in Asians. AIP is the logarithmically transformed ratio of triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C), and is thought to be associated with arteriosclerosis, hypertension, diabetes and cardiovascular diseases. Of the 463 patients from Central Hospital of Nanchong in 2011-2014 diagnosed with angiograms, 229 CHD (>50% stenosis in one or more arteries) and the rest 234 were the controls (maximum stenosis < 10% in any artery) according to the world health organization (who) diagnostic criteria. The multiple regression analysis showed that AIP was independently associated with CHD in men (odds ratio (OR) = 4.44, 95%CI 1.62-12.21, P = 0.004) after adjusting for age, body mass index (BMI), fasting blood glucose(FBG), homocysteine (Hcy), and smoking, but not in women (OR = 0.47, 95%CI 0.11-2.08, P = 0.318). Subgroup analysis showed that the significant difference in AIP between the CHD and the controls only exists in patients with multi-vessel lesions but not in those with single-vessel lesion. Further large-scale studies with balanced sex ratio and vessel lesion numbers should verify the present findings.
很少有研究调查血浆致动脉粥样硬化指数(AIP)与冠心病(CHD)之间的相互关系,特别是在亚洲人群中。AIP 是甘油三酯(TG)与高密度脂蛋白胆固醇(HDL-C)的对数比值,被认为与动脉粥样硬化、高血压、糖尿病和心血管疾病有关。2011 年至 2014 年,南充市中心医院对 463 名接受血管造影检查的患者进行了研究,根据世界卫生组织(WHO)的诊断标准,229 名患者患有 CHD(一条或多条动脉狭窄程度超过 50%),其余 234 名患者为对照组(任何动脉的最大狭窄程度<10%)。多因素回归分析显示,在校正年龄、体重指数(BMI)、空腹血糖(FBG)、同型半胱氨酸(Hcy)和吸烟等因素后,AIP 与男性 CHD 独立相关(比值比(OR)=4.44,95%可信区间 1.62-12.21,P=0.004),但在女性中不相关(OR=0.47,95%可信区间 0.11-2.08,P=0.318)。亚组分析显示,CHD 患者与对照组之间 AIP 的差异仅存在于多支血管病变患者中,而在单支血管病变患者中不存在差异。需要进一步开展具有均衡性别比例和血管病变数量的大规模研究来验证本研究结果。